The use of topical hemostatic agents in spinal surgery

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

During spinal surgery, it is important to achieve accurate and rapid haemostasis to reduce blood loss, operating and anaesthesia time and thereby reduce the incidence of complications. Therefore, the availability of modern, effective and safe topical haemostatic agents is an important basis for successful control of this complication, which in turn leads to a reduction in the negative impact on the patient and the economic cost of treatment. In this paper, we have analysed literature data on haemostatic agents used in spinal surgery. Based on this data, their efficacy and safety in relation to the patient and the likelihood of side effects were assessed. Further development, improvement and use of haemostatic agents should focus on increasing their efficacy and safety.

作者简介

Sergey Kolesov

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: dr-kolesov@yandex.ru
ORCID iD: 0000-0001-9657-8584
SPIN 代码: 1989-6994

MD, Dr. Sci. (Medicine), professor

俄罗斯联邦, Moscow

Aleksandr Vasilev

Priorov National Medical Research Center of Traumatology and Orthopedics

编辑信件的主要联系方式.
Email: aleksandr-wasilew@yandex.ru

MD

俄罗斯联邦, Moscow

Anton Shakhin

St Vladimir’s Children’s Clinical Hospital

Email: dr-shakhin@inbox.ru

MD, Cand. Sci. (Medicine), associate professor

俄罗斯联邦, Moscow

Sergei Rassovskiy

St Vladimir’s Children’s Clinical Hospital

Email: aleksandr-wasilew@yandex.ru

MD

俄罗斯联邦, Moscow

Arkadiy Kazmin

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: kazmin.cito@mail.ru
ORCID iD: 0000-0003-2330-0172

MD, Cand. Sci. (Medicine)

俄罗斯联邦, Moscow

Vladimir Shvets

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: vshvecv@yandex.ru
ORCID iD: 0000-0001-8884-2410

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Moscow

Vladimir Pereverzev

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: vcpereverz@gmail.com
ORCID iD: 0000-0002-6895-8288

MD

俄罗斯联邦, Moscow

Sergei Baranov

St Vladimir’s Children’s Clinical Hospital

Email: drbaranov-sa@mail.ru

MD

俄罗斯联邦, Moscow

Tagir Abdulin

St Vladimir’s Children’s Clinical Hospital

Email: tag8787@mail.ru

MD

俄罗斯联邦, Moscow

Samir Bagirov

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: bagirov.samir22@gmail.com
ORCID iD: 0000-0003-1038-1815
SPIN 代码: 9620-7038

MD

俄罗斯联邦, Moscow

Nataliia Morozova

Priorov National Medical Research Center of Traumatology and Orthopedics

Email: morozcito@gmail.com
ORCID iD: 0000-0003-4504-6902
SPIN 代码: 4593-3231

MD, Cand. Sci. (Medicine)

俄罗斯联邦, Moscow

Elizaveta Bibikova

St Vladimir’s Children’s Clinical Hospital

Email: muchacha15@yandex.ru
ORCID iD: 0000-0002-1051-7690

MD

俄罗斯联邦, Moscow

参考

  1. Ramirez MG, Deutsch H, Khanna N, et al. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hosp Pract (1995). 2018;46(4):189–196. doi: 10.1080/21548331.2018.1498279
  2. Szpalski M, Gunzburg R, Sztern B. An overview of blood-sparing techniques used in spine surgery during the perioperative period. Eur Spine J. 2004;13 Suppl 1(Suppl 1):S18–27. doi: 10.1007/s00586-004-0752-y
  3. Signorelli F, Montano N. Use and Efficacy of Hemostats in Neurosurgery. Surg Technol Int. 2020;37:414–419.
  4. Fineberg SJ, Oglesby M, Patel AA, Singh K. Incidence and mortality of perioperative cardiac events in cervical spine surgery. Spine (Phila Pa 1976). 2013;38(15):1268–74. doi: 10.1097/BRS.0b013e318290fdac
  5. Kimura A, Ohmori T, Sakata A, et al. Hemostatic function to regulate perioperative bleeding in patients undergoing spinal surgery: A prospective observational study. PLoS One. 2017;12(6):e0179829. doi: 10.1371/journal.pone.0179829
  6. Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135. doi: 10.1186/1472-6963-11-135
  7. Zemlyanoj A.B. Sredstvo mestnogo gemostaza — tekuchaya aktivnaya gemostaticheskaya matrica. Hirurgiya. Zhurnal im. N.I. Pirogova. 2019;(5):104–115. (In Russ.). doi: 10.17116/hirurgia2019051104
  8. Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther. 2013;13(12):1663–72. doi: 10.1517/14712598.2013.848193
  9. Le Huec JC, AlEissa S, Bowey AJ, et al. Hemostats in Spine Surgery: Literature Review and Expert Panel Recommendations. Neurospine. 2022;19(1):1–12. doi: 10.14245/ns.2143196.59
  10. Tan H, Pan S, Wei C, Chen Z, Chen T. Comparative efficacy and safety of different hemostatic medications during spinal surgery: A network meta-analysis. Medicine (Baltimore). 2023;102(9):e32923. doi: 10.1097/MD.0000000000032923
  11. Korotkevich AG, Antonov YUA, Lobykin FI, Kuznecov VV. «Oksigeniruyushchij» gemostaz pri aktivnom yazvennom krovotechenii. Medicina v Kuzbasse. 2004;3(3):20–23. (In Russ.). EDN: KYOUPV
  12. Chen H, Yang J-S, Zou P, et al. Safety and Efficacy of Hydrogen Peroxide in Controlling Blood Loss and Surgical Site Infection After Multisegmental Lumbar Spine Surgery: A Retrospective, Case-Controlled Study. World Neurosurg. 2020;133:e303–e307. doi: 10.1016/j.wneu.2019.09.005
  13. Zou P, Yang J-S, Wang X-F, et al. Oxygen Embolism and Pneumocephalus After Hydrogen Peroxide Application During Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery: A Case Report and Literature Review. World Neurosurg. 2020;138:201–204. doi: 10.1016/j.wneu.2020.03.035
  14. Zhao S-L, Zhang X-Y, Xiao Y, et al. Gas Embolism After Hydrogen Peroxide Use During Spine Surgery: Case Report and Literature Review. World Neurosurg. 2020;143:228–231. doi: 10.1016/j.wneu.2020.07.210
  15. Mehta MH. The rib-vertebra angle in the early diagnosis between resolving and progressive infantile scoliosis. J Bone Joint Surg Br. 1972;54(2):230–43.
  16. Li J, Wang L, Bai T, Liu Y, Huang Y. Combined use of intravenous and topical tranexamic acid efficiently reduces blood loss in patients aged over 60 operated with a 2-level lumbar fusion. J Orthop Surg Res. 2020;15(1):339. doi: 10.1186/s13018-020-01758-8
  17. Xiong Z, Liu J, Yi P, Wang H, Tan M. Comparison of Intravenous versus Topical Tranexamic Acid in Nondeformity Spine Surgery: A Meta-Analysis. Biomed Res Int. 2020;2020:7403034. doi: 10.1155/2020/7403034
  18. Eikebrokk TA, Vassmyr BS, Ausen K, et al. Cytotoxicity and effect on wound re-epithelialization after topical administration of tranexamic acid. BJS Open. 2019;3(6):840–851. doi: 10.1002/bjs5.50192
  19. Neveleff DJ. Optimizing hemostatic practices: matching the appropriate hemostat to the clinical situation. AORN J. 2012;96(5):S1–S17. doi: 10.1016/j.aorn.2012.08.005
  20. Spotnitz WD, Burks S. State-of-the-art review: Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost. 2010;16(5):497–514. doi: 10.1177/1076029610363589
  21. Hickman DA, Pawlowski CL, Sekhon UDS, Marks J, Gupta A Sen. Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. Adv Mater. 2018;30(4):10.1002/adma.201700859. doi: 10.1002/adma.201700859
  22. Huang L, Liu GL, Kaye AD, Liu H. Advances in Topical Hemostatic Agent Therapies: A Comprehensive Update. Adv Ther. 2020;37(10):4132–4148. doi: 10.1007/s12325-020-01467-y
  23. Chiara O, Cimbanassi S, Bellanova G, et al. A systematic review on the use of topical hemostats in trauma and emergency surgery. BMC Surg. 2018;18(1):68. doi: 10.1186/s12893-018-0398-z
  24. Echave M, Oyagüez I, Casado MA. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. MC Surg. 2014;14:111. doi: 10.1186/1471-2482-14-111
  25. Centeno A, Rojas S, Arias B, et al. Experimental Evaluation of a New Tissue Factor-Based Topical Hemostat (TT-173) for Treatment of Hepatic Bleeding. J Invest Surg. 2020;33(4):339–349. doi: 10.1080/08941939.2018.1517840
  26. Lai M, Zhou S, He S, et al. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database Syst Rev. 2023;6(6):CD009621. doi: 10.1002/14651858
  27. Bruckner BA, Blau LN, Rodriguez L, et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg. 2014;9:134. doi: 10.1186/s13019-014-0134-4
  28. Wright NM, Park J, Tew JM, et al. Spinal sealant system provides better intraoperative watertight closure than standard of care during spinal surgery: a prospective, multicenter, randomized controlled study. Spine (Phila Pa 1976). 2015;40(8):505–13. doi: 10.1097/BRS.0000000000000810
  29. Xiong GX, Tobert D, Fogel H, et al. Open epidural blood patch to augment durotomy repair in lumbar spine surgery: surgical technique and cohort study. Spine J. 2021;21(12):2010–2018. doi: 10.1016/j.spinee.2021.06.011
  30. Sundaram CP, Keenan AC. Evolution of hemostatic agents in surgical practice. Indian J Urol. 2010;26(3):374–8. doi: 10.4103/0970-1591.70574
  31. Mikhail C, Pennington Z, Arnold PM, et al Minimizing Blood Loss in Spine Surgery. Global Spine J. 2020;10(1 Suppl):71S–83S. doi: 10.1177/2192568219868475
  32. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: Bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13 Suppl 1(Suppl 1):S89–96. doi: 10.1007/s00586-004-0727-z
  33. Le Huec JC, Aleissa S, Bowey AJ, et al. Hemostats in Spine Surgery: Literature Review and Expert Panel Recommendations. Neurospine. 2022;19(1):1–12. doi: 10.14245/ns.2143196.598
  34. Song Y, Nagai N, Saijo S, et al. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. Mater Sci Eng C Mater Biol Appl. 2018;88:1–12. doi: 10.1016/j.msec.2018.02.022
  35. Ji P, Jiang Y, Hou W, Li Q, Kang Y. A Rare Case of Fatal Pulmonary Embolism in a Pediatric Spine Surgery. World Neurosurg. 2020;137:183–186. doi: 10.1016/j.wneu.2020.01.225
  36. Skovrlj B, Mascitelli JR, Camins MB, Doshi AH, Qureshi SA. Acute respiratory failure from Surgifoam expansion after anterior cervical surgery: case report. J Neurosurg Spine. 2013;19(4):428–30. doi: 10.3171/2013.7.SPINE1328
  37. Alander DH, Stauffer ES. Gelfoam-induced acute quadriparesis after cervical decompression and fusion. Spine (Phila Pa 1976). 1995;20(8):970–1. doi: 10.1097/00007632-199504150-00016
  38. Friedman J, Whitecloud TS 3rd. Lumbar cauda equina syndrome associated with the use of gelfoam: case report. Spine (Phila Pa 1976). 2001;26(20):E485–7. doi: 10.1097/00007632-200110150-00029
  39. Haws BE, Khechen B, Patel D V, et al. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial. J Neurosurg Spine. 2018;30(2):222–227. doi: 10.3171/2018.7.SPINE18584
  40. Liang J, Liu H, Huang X, et al. Using tranexamic acid soaked absorbable gelatin sponge following complex posterior lumbar spine surgery: A randomized control trial. Clin Neurol Neurosurg. 2016;147:110–4. doi: 10.1016/j.clineuro.2016.06.001
  41. Bessette MC, Mesfin A. Cauda equina syndrome caused by retained hemostatic agents. J Clin Neurosci. 2015;22(9):1518–20. doi: 10.1016/j.jocn.2015.03.021
  42. Rustagi T, Patel K, Kadrekar S, Jain A. Oxidized Cellulose (Surgicel) Causing Postoperative Cauda Equine Syndrome. Cureus. 2017;9(7):e1500. doi: 10.7759/cureus.1500
  43. Abbott WM, Austen WG. The effectiveness and mechanism of collagen-induced topical hemostasis. Surgery. 1975;78(6):723–9.
  44. Lewis KM, Spazierer D, Slezak P, et al. Swelling, sealing, and hemostatic ability of a novel biomaterial: A polyethylene glycol-coated collagen pad. J Biomater Appl. 2014;29(5):780–8. doi: 10.1177/0885328214545500
  45. Zhang S, Li J, Chen S, et al. Oxidized cellulose-based hemostatic materials. Carbohydr Polym. 2020;230:115585. doi: 10.1016/j.carbpol.2019.115585
  46. Sae-Jung S, Apiwatanakul P. Chitosan Pad, Cellulose Membrane, or Gelatin Sponge for Peridural Bleeding: An Efficacy Study on a Lumbar Laminectomized Rat Model. Asian Spine J. 2018;12(2):195–201. doi: 10.4184/asj.2018.12.2.195
  47. Cheng F, Wu Y, Li H, et al. Biodegradable N, O-carboxymethyl chitosan/oxidized regenerated cellulose composite gauze as a barrier for preventing postoperative adhesion. Carbohydr Polym. 2019;207:180–190. doi: 10.1016/j.carbpol.2018.10.077
  48. Roshkovan L, Singhal S, Katz SI, Galperin-Aizenberg M. Multimodality imaging of Surgicel(®), an important mimic of post-operative complication in the thorax. BJR Open. 2021;3(1):20210031. doi: 10.1259/bjro.20210031
  49. Corti MC, Thomas AD, Sayegh MN, et al. Surgicel-Induced Anaphylaxis Post Permacath Placement. Cureus. 2021;13(8):e16938. doi: 10.7759/cureus.1693
  50. Azami Hassani FE-Z, Slimani F. SURGICEL mimicking a recurrence of a temporomandibular joint chondrosarcoma. Ann Med Surg (Lond). 2021;63:102187. doi: 10.1016/j.amsu.2021.102187
  51. Turkyilmaz Z, Karabulut R, Kaya C, et al. Surgicel mimicking recurrent pelvic neuroblastoma in a 3-year-old boy. Acta Chir Belg. 2022;122(4):266–268. doi: 10.1080/00015458.2020.1846944
  52. Sabel M, Stummer W. The use of local agents: Surgicel and Surgifoam. Eur Spine J. 2004;13 Suppl 1(Suppl 1):S97–101. doi: 10.1007/s00586-004-0735-z
  53. Kovalenko RA, Ptashnikov DA, Savello AV, et al. A rare case of treatment of giant paravertebral arteriovenous malformation combined with idiopathic scoliosis. Spine Surgery. 2019;16(3):47–54. doi: 10.14531/ss2019.3.47-54
  54. Slezak P, Keibl C, Labahn D, et al. A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM(®)) With A Gelatin Sponge Carrier Versus Topical Oxidized Regenerated Cellulose (TABOTAMP(®)/SURGICEL(®)) In A Porcine Liver Bleeding Model. J Invest Surg. 2021;34(8):862–868. doi: 10.1080/08941939.2019.1705444
  55. Ahn DK, Shin WS, Kim GW, Koo KH. Postoperative Spinal Epidural Hematoma: The Danger Caused by the Misuse of Thrombin-Containing Local Hemostatics. Asian Spine J. 2017;11(6):898–902. doi: 10.4184/asj.2017.11.6.898
  56. Rodgers GM. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature. J Pediatr Hematol Oncol. 2011;33(2):86–8. doi: 10.1097/MPH.0b013e3181ff0e43
  57. Park HJ, Suk KS, Park JW. A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin. Allergy Asthma Immunol Res. 2018;10(2):184–186. doi: 10.4168/aair.2018.10.2.184
  58. Minkowitz H, Navarro-Puerto J, Lakshman S, et al. Prospective, Randomized, Phase II, Non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery. J Am Coll Surg. 2019;229(5):497–507.e1. doi: 10.1016/j.jamcollsurg.2019.07.008
  59. Landi A, Gregori F, Marotta N, Delfini R. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo. J Neurol Surg A Cent Eur Neurosurg. 2016;77(2):139–43. doi: 10.1055/s-0035-1558413
  60. Danker W, Kelkar SS, Marston XL, Aggarwal J, Johnston SS. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery. J Comp Eff Res. 2022;11(17):1231–1240. doi: 10.2217/cer-2021-0218
  61. Nechepurenko AA, Ilov NN, Durmanov SS, et al. Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial. Card Arrhythm. 2021;1(1):17–24. (In Russ.). doi: 10.17816/cardar70497
  62. Plotkin AV, Pokrovskij EZH, Voronova GV, Menglet KA. Ocenka effektivnosti gemostaticheskogo dejstviya preparata Gemoblok pri polostnyh i laparoskopicheskih vmeshatel’stvah: mul’ticentrovye klinicheskie issledovaniya. Vestnik sovremennoj klinicheskoj mediciny. 2015;8(1):56–61. (In Russ.). EDN: THWGPP
  63. Kuznecova MV, Parshakov AA, Kuznecova MP, et al. Vliyanie hirurgicheskogo gemostaticheskogo preparata «Gemoblok» na bakterial’nuyu kolonizaciyu in vitro. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2020;22(1):67–70. (In Russ.). doi: 10.36488/cmac.2020.1.67-70
  64. Bajrikov I, Blohina EV. Ispol’zovanie medicinskogo preparata “GEMOBLOK DENT” u bol’nyh s gemofiliej v stomatologii. Sovremennaya nauka: aktual’nye problemy teorii i praktiki. Seriya: Estestvennye i tekhnicheskie nauki. 2019;(8):146–148. (In Russ.). EDN: XMITSS
  65. Polyancev AA, Kaplunova EV, Karpenko SN, Linchenko AM. Pervyj opyt klinicheskogo primeneniya gemostaticheskogo sredstva « GEMOBLOK » pri endosokpicheskom gemostaze. Vestnik Volgogradskogo gosudarstvennogo medicinskogo universiteta. 2015;(2):32–33. (In Russ.). EDN: TXGOIJ
  66. Dumville JC, Coulthard P, Worthington HV, et al. Tissue adhesives for closure of surgical incisions. Cochrane Database Syst Rev. 2014;2014(11):CD004287. doi: 10.1002/14651858.CD004287.pub4
  67. Yamagami T, Kanda K, Kato T, et al. Embolisation of proximal anastomotic pseudoaneurysm developing after surgical repair of abdominal aortic aneurysm with a bifurcated graft with n-butyl cyanoacrylate. Br J Radiol. 2006;79(948):e193–5. doi: 10.1259/bjr/97367208
  68. Tan T, Rutges J, Marion T, Hunn M, Tee J. Cyanoacrylate Dermal Closure in Spine Surgery: Systematic Review and Pooled Analysis. Global Spine J. 2020;10(4):493–498. doi: 10.1177/2192568219861619
  69. Ando M, Tamaki T, Yoshida M, et al. Surgical site infection in spinal surgery: a comparative study between 2-octyl-cyanoacrylate and staples for wound closure. Eur Spine J. 2014;23(4):854–62. doi: 10.1007/s00586-014-3202-5
  70. Pace Napoleone C, Oppido G, Angeli E, Gargiulo G. Resternotomy in pediatric cardiac surgery: CoSeal initial experience. Interact Cardiovasc Thorac Surg. 2007;6(1):21–3. doi: 10.1510/icvts.2006.141531
  71. Kolesov SV, Grin AA, Slinyakov LY, et al. Effektivnost’ ispol’zovaniya serebryanoj soli poliakrilovoj kisloty pri dekompressionno- stabiliziruyushchih operaciyah na poyasnichnom otdele pozvonochnika s zahvatom 1–3 segmentov. Hirurgiya pozvonochnika. 2019;16(2):73–80. (In Russ.). doi: 10.14531/ss2019.2.73-80
  72. Baird EO, McAnany SJ, Lu Y, Overley SC, Qureshi SA. Hemostatic Agents in Spine Surgery: A Critical Analysis Review. JBJS Rev. 2015;3(1):e2. doi: 10.2106/JBJS.RVW.N.00027

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Eco-Vector, 2025

许可 URL: https://eco-vector.com/for_authors.php#07

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».